Your partners in health.
Developing new life changing medicines.
Villya is taking traditional pharmaceuticals and making them better. Using our patented technology we are removing ingredients and reducing doses.
483 second generation pharmaceuticals under patent!
100% water soluble and rapid loading!
We care and every day we are working hard for you.
Liquid Praziquantel
Selicide®
Patent pending
Our scientist have made a break through discovery that will allow children to have access to this life saving drug.
Liquid Praziquantel is not only easily administered orally but it now can be accurately dosed in a ml solution, no more guessing by breaking large pills. Villya's new form of Praziquantel is not only liquid it is more effective as it is water-soluble. VILYA'S technology allows us to deliver the drug any way we would like. Our praziquantle is available as a pill, chewable, liquid or intectable.
Worlds First View of Water Soluble Pharmaceuticals!
Villasel/Inlasel
U.S. Patent# 10,857,151
A drug to treat FGS Schistosomiasis
A drug for Female Vaginal Schistosomiasis (FGS)
Our research has led Villya to the discovery that Female Vaginal Schistosomiasis is a disease having its own biome and needs to be treated as such. Oral Praziquantel does not have the power to penetrate this alone so we have developed our new drug Villasel. This drug works as a topical gel administered directly to the sight of the infection clearing the parasites. Villya designed this drug specifically to eliminate the threat so we combined our two active ingredients to eliminate not only the adult worms but the juveniles and egg!
By eliminating the cause of FGS we are able to save the patient from cervical cancer related to FGS and HIV exposure
WATER SOLUBLE SILDENAFIL CRYSTALS
VILYA'S technology allows us to deliver the drug any way we would like. Our Sildenafil is available as a pill, chewable, liquid, gel or intectable.
Our Little Blue Pill is different.
VILLYA'S NEW 100% WATER SOLUBLE SILDENAFIL
IT TAKES AFFECT IN AS LITTLE AS 3 MINUTES
US PATENT# 12,115,222 B2
Our team that's making pharmaceuticals healther
CEO
(CHIEF EXECUTIVE OFFICER)
William Miller
Inventor of Villya's Technology
William is a visionary leader with extensive experience in international diplomacy, aerospace, and pharmaceutical innovation. He attended Indiana State University and began his distinguished career contracting at the U.S. Department of State, serving for nearly a decade on a Medevac team within the International Narcotics and Law Enforcement division across multiple U.S. Embassies overseas. This role allowed William to hone his diplomatic skills and build a robust network of international contacts.
Upon returning to the United States, William was recruited by SpaceX to contribute to the Dragon Project, playing an integral role in achieving critical milestones for the successful launch of U.S.-manufactured spacecraft with astronauts on board.
In his entrepreneurial journey, William founded S7LLC, a medical device company focused on importing and licensing rapid diagnostic tests for Schistosomiasis and COVID-19. He later transformed S7LLC into ICT International, where, as President, he expanded the company's offerings to 13 different rapid diagnostic tests for infectious diseases globally.
In his pursuit of innovation in the pharmaceutical industry, William founded Villya Pharmaceuticals, where he created and patented a groundbreaking drug to treat Female Genital Schistosomiasis (FGS) (approval US 10,857,151 B1). His achievements include the development of Liquid Praziquantel, a patent-pending formulation that makes the drug accessible for children by enhancing its solubility and bioavailability through Villya's patented carbohydrate loading technology. Villya has since patented 483 life-saving drugs, transforming them into water-soluble aggregates that are easily absorbed.
A pioneer of excellence, William played a crucial role in securing the U.S. patent office's approval for Erectile Dysfunction Therapeutics (US 12,115,222 B2) on October 15, 2024, covering five second-generation ED medications. In early 2024, he divested Villya’s intellectual property related to supplements and CBD patents to form Hythlayn Inc., which now boasts over 382 improved water-soluble supplements, including the CBD family.
William is the ideal leader for Villya Pharmaceuticals' future, with his unparalleled international connections, diplomacy skills, and a remarkable track record of managing government and private projects worth over $700 million.
This version of the bio presents William Miller's career in a coherent and professional manner, highlighting his leadership and achievements across different sectors.
CSO
(CHIEF SCIENTIFIC OFFICER)
Sreeshailam Aare
Ph.D Organic Chemistrey
CMO
(CHIEF MEDICAL OFFICER)
Christopher Thaver
Ph.D - MD
Contact Us
Don't be afraid to reach out.
You + Us = Answers
© 2019